MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/lt.24417

Медицинская библиотека · Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2016

Liver transplantation for adenomatosis: European experience.

Chiche Laurence, David Anaelle, Adam René, Oliverius M Martin, Klempnauer Jürgen, Vibert Eric, Colledan Michele, Lerut Jan, Mazzafero V Vincenzo, Di-Sandro Stefano, Laurent Christophe, Scuderi Vincenzo, Suc Bertrand, Troisi Roberto, Bachelier Phillipe, Dumortier Jerôme, Gugenheim Jean, Mabrut Jean-Yves, Gonzalez-Pinto Ignacio, Pruvot François-René, Le-Treut Yves Patrice, Navarro Francis, Ortiz-de-Urbina Jorge, Salamé Ephrem, Spada Marco, Bioulac-Sage Paulette

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

The aim of this study was to collect data from patients who underwent liver transplantation (LT) for adenomatosis; to analyze the symptoms, the characteristics of the disease, and the recipient outcomes; and to better define the role of LT in this rare indication. This retrospective multicenter study, based on data from the European Liver Transplant Registry, encompassed patients who underwent LT for adenomatosis between January 1, 1986, and July 15, 2013, in Europe. Patients with glycogen storage disease (GSD) type IA were not excluded. This study included 49 patients. Sixteen patients had GSD, and 7 had liver vascular abnormalities. The main indications for transplantation were either a suspicion of hepatocellular carcinoma (HCC; 15 patients) or a histologically proven HCC (16 patients), but only 17 had actual malignant transformation (MT) of adenomas. GSD status was similar for the 2 groups, except for age and the presence of HCC on explants (P = 0.030). Three patients with HCC on explant developed recurrence after transplantation. We obtained and studied the pathomolecular characteristics for 23 patients. In conclusion, LT should remain an extremely rare treatment for adenomatosis. Indications for transplantation primarily concern the MT of adenomas. The decision should rely on morphological data and histological evidence of MT. Additional indications should be discussed on a case-by-case basis. In this report, we propose a simplified approach to this decision-making process.

Для цитирования: Chiche Laurence, David Anaelle, Adam René, Oliverius M Martin, Klempnauer Jürgen, Vibert Eric, Colledan Michele, Lerut Jan, Mazzafero V Vincenzo, Di-Sandro Stefano, Laurent Christophe, Scuderi Vincenzo, Suc Bertrand, Troisi Roberto, Bachelier Phillipe, Dumortier Jerôme, Gugenheim Jean, Mabrut Jean-Yves, Gonzalez-Pinto Ignacio, Pruvot François-René, Le-Treut Yves Patrice, Navarro Francis, Ortiz-de-Urbina Jorge, Salamé Ephrem, Spada Marco, Bioulac-Sage Paulette. Liver transplantation for adenomatosis: European experience.. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2016. DOI: 10.1002/lt.24417.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.